Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A signal amplification probe enhances sensitivity of antibodies and aptamers based Immuno-diagnostic assays.

Nussbaum O, Bar Oz M, Tilayov T, Atiya H, Dagan S.

J Immunol Methods. 2017 Sep;448:85-90. doi: 10.1016/j.jim.2017.06.001. Epub 2017 Jun 11.

PMID:
28614699
2.

Femtosecond laser: a new intradermal DNA delivery method for efficient, long-term gene expression and genetic immunization.

Zeira E, Manevitch A, Manevitch Z, Kedar E, Gropp M, Daudi N, Barsuk R, Harati M, Yotvat H, Troilo PJ, Griffiths TG 2nd, Pacchione SJ, Roden DF, Niu Z, Nussbaum O, Zamir G, Papo O, Hemo I, Lewis A, Galun E.

FASEB J. 2007 Nov;21(13):3522-33. Epub 2007 Jun 15.

PMID:
17575264
3.

Clinical evaluation (Phase I) of a human monoclonal antibody against hepatitis C virus: safety and antiviral activity.

Galun E, Terrault NA, Eren R, Zauberman A, Nussbaum O, Terkieltaub D, Zohar M, Buchnik R, Ackerman Z, Safadi R, Ashur Y, Misrachi S, Liberman Y, Rivkin L, Dagan S.

J Hepatol. 2007 Jan;46(1):37-44. Epub 2006 Oct 20.

PMID:
17112624
4.

The use of the hydrodynamic HBV animal model to study HBV biology and anti-viral therapy.

Ketzinel-Gilad M, Zauberman A, Nussbaum O, Shoshany Y, Ben-Moshe O, Pappo O, Felig Y, Ilan E, Wald H, Dagan S, Galun E.

Hepatol Res. 2006 Apr;34(4):228-37. Epub 2006 Mar 7.

PMID:
16520091
5.

Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.

Eren R, Landstein D, Terkieltaub D, Nussbaum O, Zauberman A, Ben-Porath J, Gopher J, Buchnick R, Kovjazin R, Rosenthal-Galili Z, Aviel S, Ilan E, Shoshany Y, Neville L, Waisman T, Ben-Moshe O, Kischitsky A, Foung SK, Keck ZY, Pappo O, Eid A, Jurim O, Zamir G, Galun E, Dagan S.

J Virol. 2006 Mar;80(6):2654-64.

6.

Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.

Hanuka N, Sikuler E, Tovbin D, Neville L, Nussbaum O, Mostoslavsky M, Orgel M, Yaari A, Manor S, Dagan S, Hilzenrat N, Shemer-Avni Y.

J Med Virol. 2004 Aug;73(4):529-35.

PMID:
15221896
7.

Small interfering RNA inhibits hepatitis B virus replication in mice.

Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E.

Mol Ther. 2003 Nov;8(5):769-76.

8.

The Trimera mouse: a system for generating human monoclonal antibodies and modeling human diseases.

Ilan E, Eren R, Lubin I, Nussbaum O, Zauberman A, Dagan S.

Curr Opin Mol Ther. 2002 Apr;4(2):102-9. Review.

PMID:
12044030
9.

The hepatitis C virus (HCV)-Trimera mouse: a model for evaluation of agents against HCV.

Ilan E, Arazi J, Nussbaum O, Zauberman A, Eren R, Lubin I, Neville L, Ben-Moshe O, Kischitzky A, Litchi A, Margalit I, Gopher J, Mounir S, Cai W, Daudi N, Eid A, Jurim O, Czerniak A, Galun E, Dagan S.

J Infect Dis. 2002 Jan 15;185(2):153-61. Epub 2002 Jan 3.

PMID:
11807688
10.

Preclinical evaluation of two human anti-hepatitis B virus (HBV) monoclonal antibodies in the HBV-trimera mouse model and in HBV chronic carrier chimpanzees.

Eren R, Ilan E, Nussbaum O, Lubin I, Terkieltaub D, Arazi Y, Ben-Moshe O, Kitchinzky A, Berr S, Gopher J, Zauberman A, Galun E, Shouval D, Daudi N, Eid A, Jurim O, Magnius LO, Hammas B, Reisner Y, Dagan S.

Hepatology. 2000 Sep;32(3):588-96.

PMID:
10960454
11.

Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo.

Galun E, Nahor O, Eid A, Jurim O, Rose-John S, Blum HE, Nussbaum O, Ilan E, Daudi N, Shouval D, Reisner Y, Dagan S.

Virology. 2000 May 10;270(2):299-309.

12.

The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.

Ilan E, Burakova T, Dagan S, Nussbaum O, Lubin I, Eren R, Ben-Moshe O, Arazi J, Berr S, Neville L, Yuen L, Mansour TS, Gillard J, Eid A, Jurim O, Shouval D, Reisner Y, Galun E.

Hepatology. 1999 Feb;29(2):553-62.

PMID:
9918935
13.

Functional and structural interactions between measles virus hemagglutinin and CD46.

Nussbaum O, Broder CC, Moss B, Stern LB, Rozenblatt S, Berger EA.

J Virol. 1995 Jun;69(6):3341-9.

16.

CD26 antigen and HIV fusion?

Broder CC, Nussbaum O, Gutheil WG, Bachovchin WW, Berger EA.

Science. 1994 May 20;264(5162):1156-9; author reply 1162-5. No abstract available.

PMID:
7909959
18.

Analysis of the functional and host range-determining regions of the murine ectropic and amphotropic retrovirus envelope proteins.

Morgan RA, Nussbaum O, Muenchau DD, Shu L, Couture L, Anderson WF.

J Virol. 1993 Aug;67(8):4712-21.

19.
21.

An inducer of NKCF (NK cytotoxic factor) release: localization on target-cell membrane and initial characterization.

Reiter Z, Loyter A, Nussbaum O, Rubinstein M.

Cell Immunol. 1992 Jul;142(2):370-84.

PMID:
1377986
22.

Resistance to NK cell-mediated cytotoxicity (in K-562 cells) does not correlate with class I MHC antigen levels.

Reiter Z, Reiter Y, Fishelson Z, Shinitzky M, Kessler A, Loyter A, Nussbaum O, Rubinstein M.

Immunobiology. 1991 Sep;183(1-2):23-39.

PMID:
1657763
23.

Enhancement of the fibrinolytic activity of sheep endothelial cells by retroviral vector-mediated gene transfer.

Dichek DA, Nussbaum O, Degen SJ, Anderson WF.

Blood. 1991 Feb 1;77(3):533-41.

PMID:
1899348
24.

Reconstitution of fusogenic Sendai virus envelopes by the use of the detergent chaps.

Ran S, Nussbaum O, Loyter A, Marikovsky Y, Rivnay B.

Arch Biochem Biophys. 1988 Mar;261(2):437-46.

PMID:
2451470
25.

Animal viruses are able to fuse with prokaryotic cells. Fusion between Sendai or influenza virions and Mycoplasma.

Citovsky V, Rottem S, Nussbaum O, Laster Y, Rott R, Loyter A.

J Biol Chem. 1988 Jan 5;263(1):461-7.

26.

Fusion of enveloped viruses with biological membranes. Fluorescence dequenching studies.

Chejanovsky N, Nussbaum O, Loyter A, Blumenthal R.

Subcell Biochem. 1988;13:415-56. Review. No abstract available.

PMID:
2577862
27.
29.
30.

Membrane-bound antiviral antibodies as receptors for Sendai virions in receptor-depleted erythrocytes.

Nussbaum O, Zakai N, Loyter A.

Virology. 1984 Oct 30;138(2):185-97.

PMID:
6093364
31.

The use of specific antibodies to mediate fusion between Sendai virus envelopes and living cells.

Loyter A, Tomasi M, Gitman AG, Etinger L, Nussbaum O.

Ciba Found Symp. 1984;103:163-80.

PMID:
6323106
32.

[Some aspects of carbohydrate and lipid metabolism in obese children].

Puskás G, Eperjessy A, Nussbaum O, Nussbaum V, Indig B, Gottherer I, Máthé I.

Pediatria (Bucur). 1974 Jan;23(1):11-8. Romanian. No abstract available.

PMID:
4840988
33.

[Morphological changes of the endocrine pancreas in infantile dystrophy].

Nussbaum O, Puskás G, Kimény G, Nagy V.

Pediatria (Bucur). 1970 Mar-Apr;19(2):117-29. Romanian. No abstract available.

PMID:
4914400
34.

[On the viral etiology of acute rheumatism. IX].

Abraham A, Sabău M, Nussbaum O.

Stud Cercet Inframicrobiol. 1970;21(4):281-90. Romanian. No abstract available.

PMID:
5312505
35.

[Changes of potassium in relation to blood sugar and the insulin effect in diabetic children].

Puskás G, Nussbaum V, Indig B, Nussbaum O, Szabo M.

Pediatria (Bucur). 1968 Jul-Aug;17(4):299-307. Romanian. No abstract available.

PMID:
5701380

Supplemental Content

Loading ...
Support Center